This invention relates to compounds that alter PPAR activity. The invention
also relates to pharmaceutically acceptable salts of the compounds,
pharmaceutically acceptable compositions comprising the compounds or their
salts, and methods of using them as therapeutic agents for treating or
preventing dyslipidemia, hypercholesterolemia, obesity, hyperglycemia,
atherosclerosis, hypertriglyceridemia and hyperinsulinemia in a mammal.
The present invention also relates to methods for making the disclosed
compounds.